Fjell Capital LLC Buys Shares of 1,694 UnitedHealth Group Incorporated (NYSE:UNH)

Fjell Capital LLC bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 1,694 shares of the healthcare conglomerate’s stock, valued at approximately $857,000.

Other hedge funds also recently added to or reduced their stakes in the company. Accredited Investors Inc. increased its position in shares of UnitedHealth Group by 9,235.4% during the 3rd quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock valued at $458,929,000 after purchasing an additional 776,516 shares during the period. Caisse DE Depot ET Placement DU Quebec grew its stake in UnitedHealth Group by 129.7% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock valued at $601,951,000 after purchasing an additional 581,324 shares in the last quarter. State Street Corp raised its holdings in shares of UnitedHealth Group by 1.3% during the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after purchasing an additional 563,554 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in UnitedHealth Group during the third quarter worth approximately $276,785,000. Finally, Assenagon Asset Management S.A. increased its stake in shares of UnitedHealth Group by 89.3% in the fourth quarter. Assenagon Asset Management S.A. now owns 702,722 shares of the healthcare conglomerate’s stock worth $355,479,000 after purchasing an additional 331,539 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Up 1.9 %

Shares of NYSE UNH opened at $470.49 on Wednesday. The stock has a market capitalization of $432.99 billion, a P/E ratio of 30.35, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a 50-day moving average price of $518.22 and a 200-day moving average price of $559.08. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $5.83 earnings per share. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be paid a $2.10 dividend. The ex-dividend date is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.79%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Barclays dropped their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Wells Fargo & Company cut their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Finally, Piper Sandler reduced their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.